- Global Pharma News & Resources

Global Measles, Mumps and Rubella Vaccines Market Is Growing With A CAGR Of 7.00% 2021-2028 | China National Biotech Group Company Limited (CNBG), Merck & Co., Inc., MedImmune Health, JC Green Cannabis inc., Bavarian Nordic, Sanofi, Pfizer Inc., Novartis AG

Global Measles, mumps and rubella vaccines market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the Market is growing with a CAGR of 7.00% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development both from public and government sectors are the factors responsible for the growth of this market.

Increasing incidences of pneumococcal infections increase in research and studies to develop combination vaccines for more diseases and convenience from combination vaccines also boost up the market growth serve as growth opportunities for the market. Moreover, growing demand of such formulations, increasing preference among medical practitioners and reduced logistic constraints act as market growth drivers. However, stringent regulatory policies, potential side effects and threats from bioterrorism may hamper the measles, mumps and rubella vaccines market.

Get Free Sample PDF @

Vaccines for measles, mumps and rubella can either be administered individually or in combination. Combination vaccines are a mixture of two or more vaccines that can be administered individually into a single vaccine shot. This allows individuals to get fewer shots to get benefited for more number of diseases, easing the process for both the patients and the administrators with the administration of a single shot. Therefore, combinational shots for measles, mumps and rubella vaccines (MMR vaccines) market has an advantage over individual vaccines, moreover, partnerships of manufacturers with organizations such as UNICEF (United Nations Children’s Fund) and WHO (World Health Organization) also act as drivers for the market. However, even when there have been fewer side effects, the concern for potential side effects and high prices may act as an opportunity to the individual segment and a restraint to combination segment of the market. Moreover, complex processes of studies and preparation leading to comparatively high prices of combination vaccines in most of the regions globally are expected to be a major challenge and restrict the growth combination segment of the market, however, as individual vaccines cost less (less than 1 USD for measles vaccines), individual shots may increase the market in underdeveloped and developing countries during the forecast period.

This Free report sample includes:

  • A brief introduction to the research report.
  • Graphical introduction of the regional analysis.
  • Top players in the market with their revenue analysis.
  • Selected illustrations of market insights and trends.
  • Example pages from the report.

For More Insights Get FREE Detailed TOC @

The measles, mumps and rubella vaccines market is segmented on the basis of type, age, disease type and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the measles, mumps and rubella vaccines market can be segmented into mono vaccines, combination vaccines.
  • On the basis of age, the measles, mumps and rubella vaccines market can be segmented into children, adults. Age groups of children can be sub-segmented by immunization schedule into 12-15 months and 4-6 years.
  • On the basis of disease type, the measles, mumps and rubella vaccines market can be segmented into measles, mumps, and rubella.

Leading Key Players:

The major players covered in the measles, mumps and rubella vaccines market are China National Biotech Group Company Limited (CNBG), Merck & Co., Inc., MedImmune Health, JC Green Cannabis inc., Bavarian Nordic, Sanofi, Pfizer Inc., Novartis AG, Johnsons & Johnsons Services Inc., Emergent BioSolutions Inc., GlaxoSmithKline plc., CSL Limited, Astellas Pharma Inc., CAVAC, KAKETSUKEN, Kyoto Biken Laboratories, Inc., Kyoritsuseiyaku Corporation, GREENCROSS VETS and Serum Institute of India Pvt. Ltd. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Enquire Here for, Report Enquiry, Discount and Customization @

The country section of the measles, mumps and rubella vaccines market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Why Choose DBMR?

  • Regional demand estimation and forecast
  • Pre-commodity pricing volatility
  • Technological updates analysis
  • Location Quotients Analysis
  • Raw Material Sourcing Strategy
  • Competitive Analysis
  • Product Mix Matrix
  • Vendor Management 

Access Full Report Directly @

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475



Editor Details

  • Company:
    • CDN Newswire
Last Updated: 02-Mar-2021